Because complement control by FH is mediated in part through its binding to polyanionic molecules such as heparan sulfate (HS) and HS is damaged in chronic kidney disease, we also explore the functional impact of FH and FHR-1/FHR-5 on healthy and heparinase-treated cell surfaces. This evidence concerns the gene FH and chronic kidney disease.